Search

everythinglearnresearchcommunity

for

Search:↓

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Leflunomide is more likely to help treat alopecia areata than cause it.

Fzd2 is important for skin and hair development through various signaling ways.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Permanent hair dye may cause total hair loss.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Burn scars form abnormally due to changes in wound healing, and more research is needed to improve treatments.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Burn scars heal abnormally and more research is needed to find better treatments.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Erdr1 could be a new marker for diagnosing hair loss.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.